Fludarabine Phosphate Injection recall in Canada: labelling differences
In plain language
This recall involves US-authorized Fludarabine Phosphate Injection, USP sold in Canada. It's being recalled because of important differences in labelling and packaging compared to the Canadian product. Patients should discuss any questions or concerns with their healthcare professional.
What to do
- Stop using the product immediately.
- Discuss any questions or concerns with your healthcare professional.
- Inform your healthcare professional if you experience any side effects.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Specific affected products are listed in the official notice.
Do I have this product?
This recall applies to specific products. Details are listed in the official notice.
Frequently Asked Questions
Why was this product recalled?
This recall involves US-authorized Fludarabine Phosphate Injection, USP sold in Canada. It's being recalled because of important differences in labelling and packaging compared to the Canadian product. Patients should discuss any questions or concerns with their healthcare professional.
What should consumers do?
Stop using the product immediately. Discuss any questions or concerns with your healthcare professional. Inform your healthcare professional if you experience any side effects.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
A potential safety risk has been identified with this product. Stop using it immediately and follow the instructions in the official recall notice.
When was this product recalled?
This product was recalled on October 2, 2025.
Is the Fludarabine Phosphate Injection, USP brand affected by this recall?
Yes, Fludarabine Phosphate Injection, USP products are affected by this recall. This recall involves US-authorized Fludarabine Phosphate Injection, USP sold in Canada. It's being recalled because of important differences in labelling and packaging compared to the Canadian product. Patients should discuss any questions or concerns with their healthcare professional.